Evaluation of novel dendrimer-gold complex nanoparticles for theranostic application in oncology

dc.commentshttp://3bs.uminho.pt/node/21024por
dc.contributor.authorMilivojevic, Nevenapor
dc.contributor.authorCarvalho, Mariana Rodriguespor
dc.contributor.authorCaballero, Davidpor
dc.contributor.authorRadisavljevic, Snezanapor
dc.contributor.authorRadoicic, Marijapor
dc.contributor.authorŽivanović, Markopor
dc.contributor.authorKundu, Subhas Cpor
dc.contributor.authorReis, R. L.por
dc.contributor.authorFilipović, Nenadpor
dc.contributor.authorOliveira, Joaquim M.por
dc.date.accessioned2024-03-26T11:05:26Z
dc.date.available2024-03-26T11:05:26Z
dc.date.issued2024-01
dc.date.submitted2023-12-14
dc.date.updated2024-03-21T09:30:35Z
dc.descriptionTo view the supplementary data that accompany this paper please visit the journal website at: www.tandfonline.com/doi/suppl/10.2217/nnm-2023-0355por
dc.description.abstractAim: Despite some successful examples of therapeutic nanoparticles reaching clinical stages, there is still a significant need for novel formulations in order to improve the selectivity and efficacy of cancer treatment. Methods: The authors developed two novel dendrimerâ gold (Au) complex-based nanoparticles using twodifferent synthesis routes: complexation method (formulation A) and precipitation method (formulation B). Using a biomimetic cancer-on-a-chip model, the authors evaluated the possible cytotoxicity and internalization by colorectal cancer cells of dendrimerâ Au complex-based nanoparticles. Results: The results showed promising capabilities of these nanoparticles for selectively targeting cancer cells and delivering drugs, particularly for the formulation A nanoparticles. Conclusion: This work highlights the potential of dendrimerâ Au complex-based nanoparticles as a new strategy to improve the targeting of anticancer drugs.por
dc.description.sponsorshipThis work is financially supported by the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 952603 (http://sgabu.eu/). This article reflects only the author’s view. The Commission is not responsible for any use that may be made of the information it contains. For the experimental part of the study, we acknowledge BIONECA project – Biomaterials and advanced physical techniques for regenerative cardiology and neurology (CA16122) – and the FEDER funded project 2IQBIONEURO (0624 2IQBIONEURO 6 E). M Carvalho acknowledges her postdoctoral contract TERM RES Hub – Scientific infrastructure for Tissue Engineering and Regenerative Medicine Ref Norte-01-0145-FEDER-02219015. D Caballero acknowledges the financial support from the Portuguese Foundation for Science and Technology (FCT) under the program CEEC Individual 2017 (CEECIND/00352/2017), and the project 2MATCH (PTDC/BTM-ORG/28070/2017) funded by the Programa Operacional Regional do Norte supported by European Regional Development Funds (ERDF). This work was partially supported by IET A. F. Harvey Engineering Research Award 2018 (ENG The Cancer). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.por
dc.distributioninternationalpor
dc.identifier.citationMilivojevic N., Carvalho M. R., Caballero D., Radisavljevic S., Radoicic M., Živanović M., Kundu S. C., Reis R. L., Filipović N., Oliveira J. M. Evaluation of novel dendrimer–gold complex nanoparticles for theranostic application in oncology, Nanomedicine, doi:10.2217/nnm-2023-0355, 2023por
dc.identifier.doi10.2217/nnm-2023-0355por
dc.identifier.eissn1748-6963por
dc.identifier.issn1743-5889por
dc.identifier.pmid38275157por
dc.identifier.urihttps://hdl.handle.net/1822/90035
dc.language.isoengpor
dc.peerreviewedyespor
dc.publisherTaylor & Francispor
dc.relation06242IQBIONEURO6Epor
dc.relationNorte-01-0145-FEDER-02219015por
dc.relationCEECIND/00352/2017por
dc.relationinfo:eu-repo/grantAgreement/FCT/9471 - RIDTI/PTDC%2FBTM-ORG%2F28070%2F2017/PTpor
dc.relation.isbasedonwww.tandfonline.com/doi/suppl/10.2217/nnm-2023-0355por
dc.relation.publisherversionhttps://www.futuremedicine.com/doi/epub/10.2217/nnm-2023-0355por
dc.rightsopenAccesspor
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/por
dc.subjectDendrimerspor
dc.subjectMicrofluidicspor
dc.subjectNanoparticlespor
dc.subjectAu-complexpor
dc.subjectColorectal cancerpor
dc.subjectDendrimer nanoparticlespor
dc.subjectNano-oncologypor
dc.subjectNanomedicinepor
dc.titleEvaluation of novel dendrimer-gold complex nanoparticles for theranostic application in oncologypor
dc.typearticle
dspace.entity.typePublicationen
oaire.citationEndPage497por
oaire.citationIssue6por
oaire.citationStartPage483por
oaire.citationVolume19por
oaire.versionVoRpor
sdum.journalNanomedicinepor

Ficheiros

Pacote original

A mostrar 1 - 1 de 1
A carregar...
Nome:
21024-milivojević-et-al-2024-evaluation-novel-dendrimer-gold-complex-nanoparticles-theranostic-applicatio.pdf
Tamanho:
11.75 MB
Formato:
Adobe Portable Document Format